Healthcare

The healthcare sector is supported by some very strong fundamentals including ongoing demographic changes, continued innovation across pharma devices and diagnostics, a widening of available treatments and the application of technology across traditional pathways.

As a result, a multitude of businesses are crossing into the healthcare area including consulting, technology and business services in concerted efforts to capitalise on the segment’s potential.

In the UK, the need to keep improving outcomes from National Health Service spending with a limited budget will drive adoption of technologies which improve service delivery and outcomes. The recent pandemic will accelerate adoption enabling remote access to medical professionals, changing access points for patients and improving utilisation of healthcare professionals amongst other things.

At Cavendish, we work closely with companies across the Pharma, Life Sciences, MedTech, Diagnostics, Healthcare Services and the Health and Social Care segments advising them on making the most of the opportunities available.

CASE STUDY

Cavendish announces the sale of Avicenna Holdings to Juno Health

Cavendish advised on the successful acquisition of Avicenna Holdings Limited by Juno Health Limited. Avicenna comprises 21 pharmacies, as well as a buying group operation serving more than 1,000 independent pharmacies.

Recent deals for Healthcare

OUR TEAM

Meet our experts

Cavendish’s success is based on the wealth of experience of our people. We have a team of professionals with expertise across a wide variety of sectors, deal sizes, and transaction types.

Michael Jewell

Partner, Healthcare

View profile

Our latest news

How scale-ups access later stage growth capital
The problem with being a scale-up is right there in the name – scaling. It’s hard. Put simply, when your revenue is in the low millions ...
Funding in a circular economy
Whilst the term ‘ESG’ only joined the lexicon in the mid-2000s, socially responsible investing is by no means a new phenomenon. ...
Deal or No Deal: What factors are driving a fractured return for M&A?
New Cavendish Corporate Finance Partner Karri Vuori talked to CNBC’s Squawk Box Europe about the turbulence in the deal-making market and ...

What can we help you achieve?

Get in touch

Thank you. We will be in touch soon

There was an error with the form. Please check and try again.